Aegis Wealth Management (Maryland)’s GSK GSK Stock Holding History

Aegis Wealth Management (Maryland)’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$403K	Sell	7,684 -32	-0.4%	-$1.69K	0.19%	99
2026 Q1	$426K	Sell	7,716 -139	-2%	-$7.53K	0.24%	72
2025 Q4	$385K	Sell	7,855 -388	-5%	-$18.1K	0.22%	75
2025 Q3	$356K	Sell	8,243 -216	-3%	-$8.44K	0.19%	79
2025 Q2	$328K	Sell	8,459 -200	-2%	-$7.64K	0.2%	84
2025 Q1	$335K	Buy	8,659 +200	+2%	+$7.32K	0.2%	84
2024 Q4	$286K	Buy	+8,459	New	+$305K	0.19%	85

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Aegis Wealth Management (Maryland)'s GSK Position: Q2 2026 in Review

Aegis Wealth Management (Maryland) reduced its GSK (GSK) stake by 0.41% in Q2 2026, selling an estimated $1.69K and leaving 7,684 shares worth $403K. The position accounts for 0.19% of the portfolio, ranked #99.

Aegis Wealth Management (Maryland) first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $426K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Aegis Wealth Management (Maryland) held 7,684 shares of GSK worth $403K as of Q2 2026.
Aegis Wealth Management (Maryland) sold 32 GSK shares in Q2 2026, an estimated $1.69K.
GSK made up 0.19% of Aegis Wealth Management (Maryland)'s portfolio in Q2 2026, its #99 holding.
Aegis Wealth Management (Maryland) first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
Aegis Wealth Management (Maryland)'s GSK position peaked at $426K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Aegis Wealth Management (Maryland)'s 13F filing for Q2 2026, filed 7 Aug 2026.